Cartesian Therapeutics, Inc.
RNAC
$8.84
$0.121.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.74% | -121.24% | -802.92% | -48.46% | 14.82% |
| Total Depreciation and Amortization | 32.26% | -46.80% | 25.10% | 111.89% | 200.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.87% | 2,999.24% | 1,919.18% | 62.71% | -1,002.44% |
| Change in Net Operating Assets | 380.97% | 100.96% | -100.04% | -97.95% | 95.30% |
| Cash from Operations | -20.32% | 4.21% | -152.96% | -213.94% | -21.29% |
| Capital Expenditure | 89.52% | 97.49% | 30.21% | 79.16% | -63.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 89.52% | 97.49% | -38.98% | 79.16% | -63.52% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,975.29% | 8,463.39% | -94.11% | -100.00% | -29.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -54.55% | -- | -- |
| Cash from Financing | 83,806.67% | 295.28% | -106.64% | -100.03% | -50.00% |
| Foreign Exchange rate Adjustments | -308.33% | -121.88% | 173.33% | 33.33% | -14.29% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 244.51% | 79.80% | -176.94% | -112.84% | -26.07% |